296 related articles for article (PubMed ID: 34387894)
21. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival.
Bödör C; Renneville A; Smith M; Charazac A; Iqbal S; Etancelin P; Cavenagh J; Barnett MJ; Kramarzová K; Krishnan B; Matolcsy A; Preudhomme C; Fitzgibbon J; Owen C
Haematologica; 2012 Jun; 97(6):890-4. PubMed ID: 22271902
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of germline GATA2 and SAMD9/9L variants in paediatric haematological disorders with monosomy 7.
Yoshida M; Tanase-Nakao K; Shima H; Shirai R; Yoshida K; Osumi T; Deguchi T; Mori M; Arakawa Y; Takagi M; Miyamura T; Sakaguchi K; Toyoda H; Ishida H; Sakata N; Imamura T; Kawahara Y; Morimoto A; Koike T; Yagasaki H; Ito S; Tomizawa D; Kiyokawa N; Narumi S; Kato M
Br J Haematol; 2020 Dec; 191(5):835-843. PubMed ID: 32770553
[TBL] [Abstract][Full Text] [Related]
23. Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency.
Rein A; Geron I; Kugler E; Fishman H; Gottlieb E; Abramovich I; Giladi A; Amit I; Mulet-Lazaro R; Delwel R; Gröschel S; Levin-Zaidman S; Dezorella N; Holdengreber V; Rao TN; Yacobovich J; Steinberg-Shemer O; Huang QH; Tan Y; Chen SJ; Izraeli S; Birger Y
Haematologica; 2023 Sep; 108(9):2316-2330. PubMed ID: 36475518
[TBL] [Abstract][Full Text] [Related]
24. Generation of two heterozygous GATA2 CRISPR/Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency.
Castaño J; Romero-Moya D; Richaud-Patin Y; Giorgetti A
Stem Cell Res; 2021 Aug; 55():102445. PubMed ID: 34284273
[TBL] [Abstract][Full Text] [Related]
25. GATA2 mutation in long stand Mycobacterium kansasii infection, myelodysplasia and MonoMAC syndrome: a case-report.
Mendes-de-Almeida DP; Andrade FG; Borges G; Dos Santos-Bueno FV; Vieira IF; da Rocha LKMDS; Mendes-da-Cruz DA; Zancopé-Oliveira RM; Calado RT; Pombo-de-Oliveira MS
BMC Med Genet; 2019 Apr; 20(1):64. PubMed ID: 31035956
[TBL] [Abstract][Full Text] [Related]
26. Skin manifestations among GATA2-deficient patients.
Polat A; Dinulescu M; Fraitag S; Nimubona S; Toutain F; Jouneau S; Poullot E; Droitcourt C; Dupuy A
Br J Dermatol; 2018 Mar; 178(3):781-785. PubMed ID: 28440875
[TBL] [Abstract][Full Text] [Related]
27. Haemophagocytic lymphohistiocytosis caused by GATA2 deficiency: a report on three patients.
Wu L; Wang J; Song D; You Y; Wang Z
BMC Infect Dis; 2024 May; 24(1):482. PubMed ID: 38730328
[TBL] [Abstract][Full Text] [Related]
28. Breaking the spatial constraint between neighboring zinc fingers: a new germline mutation in GATA2 deficiency syndrome.
Cavalcante de Andrade Silva M; Katsumura KR; Mehta C; Velloso EDRP; Bresnick EH; Godley LA
Leukemia; 2021 Jan; 35(1):264-268. PubMed ID: 32286542
[No Abstract] [Full Text] [Related]
29. Case Report: Missing zinc finger domains: hemophagocytic lymphohistiocytosis in a GATA2 deficiency patient triggered by non-tuberculous mycobacteriosis.
Huang X; Wu B; Wu D; Huang X; Shen M
Front Immunol; 2023; 14():1191757. PubMed ID: 37680631
[TBL] [Abstract][Full Text] [Related]
30. A Nationwide Study of GATA2 Deficiency in Italy Reveals Novel Symptoms and Genotype-phenotype Association.
Roncareggi S; Girardi K; Fioredda F; Pedace L; Arcuri L; Badolato R; Bonanomi S; Borlenghi E; Cirillo E; Coliva T; Consonni F; Conti F; Farruggia P; Gambineri E; Guerra F; Locatelli F; Mancuso G; Marzollo A; Masetti R; Micalizzi C; Onofrillo D; Piccini M; Pignata C; Raddi MG; Santini V; Vendemini F; Biondi A; Saettini F
J Clin Immunol; 2023 Nov; 43(8):2192-2207. PubMed ID: 37837580
[TBL] [Abstract][Full Text] [Related]
31. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents.
Wlodarski MW; Hirabayashi S; Pastor V; Starý J; Hasle H; Masetti R; Dworzak M; Schmugge M; van den Heuvel-Eibrink M; Ussowicz M; De Moerloose B; Catala A; Smith OP; Sedlacek P; Lankester AC; Zecca M; Bordon V; Matthes-Martin S; Abrahamsson J; Kühl JS; Sykora KW; Albert MH; Przychodzien B; Maciejewski JP; Schwarz S; Göhring G; Schlegelberger B; Cseh A; Noellke P; Yoshimi A; Locatelli F; Baumann I; Strahm B; Niemeyer CM;
Blood; 2016 Mar; 127(11):1387-97; quiz 1518. PubMed ID: 26702063
[TBL] [Abstract][Full Text] [Related]
32. [Clinical and molecular characteristics of GATA2 related pediatric primary myelodysplastic syndrome].
An WB; Liu C; Wan Y; Chen XY; Guo Y; Chen XJ; Yang WY; Chen YM; Zhang YC; Zhu XF
Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):477-483. PubMed ID: 31340620
[No Abstract] [Full Text] [Related]
33. Quantitative and qualitative impairments in GATA2 and myeloid neoplasms.
Shimizu R; Yamamoto M
IUBMB Life; 2020 Jan; 72(1):142-150. PubMed ID: 31675473
[TBL] [Abstract][Full Text] [Related]
34. A novel germline GATA2 frameshift mutation with a premature stop codon in a family with congenital sensory hearing loss and myelodysplastic syndrome.
Nakazawa H; Yamaguchi T; Sakai H; Maruyama M; Kawakami T; Kawakami F; Nishina S; Ishikawa M; Kosho T; Ishida F
Int J Hematol; 2021 Aug; 114(2):286-291. PubMed ID: 33759087
[TBL] [Abstract][Full Text] [Related]
35. Lethal Influenza in Two Related Adults with Inherited GATA2 Deficiency.
Sologuren I; Martínez-Saavedra MT; Solé-Violán J; de Borges de Oliveira E; Betancor E; Casas I; Oleaga-Quintas C; Martínez-Gallo M; Zhang SY; Pestano J; Colobran R; Herrera-Ramos E; Pérez C; López-Rodríguez M; Ruiz-Hernández JJ; Franco N; Ferrer JM; Bilbao C; Andújar-Sánchez M; Álvarez Fernández M; Ciancanelli MJ; Rodríguez de Castro F; Casanova JL; Bustamante J; Rodríguez-Gallego C
J Clin Immunol; 2018 May; 38(4):513-526. PubMed ID: 29882021
[TBL] [Abstract][Full Text] [Related]
36. A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT.
Jørgensen SF; Buechner J; Myhre AE; Galteland E; Spetalen S; Kulseth MA; Sorte HS; Holla ØL; Lundman E; Alme C; Heier I; Flægstad T; Fløisand Y; Benneche A; Fevang B; Aukrust P; Stray-Pedersen A; Gedde-Dahl T; Nordøy I
J Clin Immunol; 2022 Feb; 42(2):404-420. PubMed ID: 34893945
[TBL] [Abstract][Full Text] [Related]
37. Pathogenic human variant that dislocates GATA2 zinc fingers disrupts hematopoietic gene expression and signaling networks.
Jung MM; Shen S; Botten GA; Olender T; Katsumura KR; Johnson KD; Soukup AA; Liu P; Zhang Q; Jensvold ZD; Lewis PW; Beagrie RA; Low JK; Yang L; Mackay JP; Godley LA; Brand M; Xu J; Keles S; Bresnick EH
J Clin Invest; 2023 Apr; 133(7):. PubMed ID: 36809258
[TBL] [Abstract][Full Text] [Related]
38. GATA2 Deficiency in Adult Life Is Characterized by Phenotypic Diversity and Delayed Diagnosis.
Shamriz O; Zahalka N; Simon AJ; Lev A; Barel O; Mor N; Tal Y; Segel MJ; Somech R; Yonath H; Toker O
Front Immunol; 2022; 13():886117. PubMed ID: 35603181
[TBL] [Abstract][Full Text] [Related]
39. Human GATA2 mutations and hematologic disease: how many paths to pathogenesis?
Bresnick EH; Jung MM; Katsumura KR
Blood Adv; 2020 Sep; 4(18):4584-4592. PubMed ID: 32960960
[TBL] [Abstract][Full Text] [Related]
40. miR-181c regulates MCL1 and cell survival in GATA2 deficient cells.
Wang W; Chen R; Droll S; Barber E; Saleh L; Corrigan-Cummins M; Trick M; Anastas V; Hawk NV; Zhao Z; Vinh DC; Hsu A; Hickstein DD; Holland SM; Calvo KR
J Leukoc Biol; 2022 Apr; 111(4):805-816. PubMed ID: 34270823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
